• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多聚泛素化 PCNA 触发 SLX4 介导的断裂诱导复制,在端粒延长(ALT)癌症细胞中。

Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells.

机构信息

Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Korea.

Department of Biological Sciences, College of Information-Bio Convergence Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea.

出版信息

Nucleic Acids Res. 2024 Oct 28;52(19):11785-11805. doi: 10.1093/nar/gkae785.

DOI:10.1093/nar/gkae785
PMID:39291733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514459/
Abstract

Replication stresses are the major source of break-induced replication (BIR). Here, we show that in alternative lengthening of telomeres (ALT) cells, replication stress-induced polyubiquitinated proliferating cell nuclear antigen (PCNA) (polyUb-PCNA) triggers BIR at telomeres and the common fragile site (CFS). Consistently, depleting RAD18, a PCNA ubiquitinating enzyme, reduces the occurrence of ALT-associated promyelocytic leukemia (PML) bodies (APBs) and mitotic DNA synthesis at telomeres and CFS, both of which are mediated by BIR. In contrast, inhibiting ubiquitin-specific protease 1 (USP1), an Ub-PCNA deubiquitinating enzyme, results in an increase in the above phenotypes in a RAD18- and UBE2N (the PCNA polyubiquitinating enzyme)-dependent manner. Furthermore, deficiency of ATAD5, which facilitates USP1 activity and unloads PCNAs, augments recombination-associated phenotypes. Mechanistically, telomeric polyUb-PCNA accumulates SLX4, a nuclease scaffold, at telomeres through its ubiquitin-binding domain and increases telomere damage. Consistently, APB increase induced by Ub-PCNA depends on SLX4 and structure-specific endonucleases. Taken together, our results identified the polyUb-PCNA-SLX4 axis as a trigger for directing BIR.

摘要

复制应激是引发复制诱导的断裂(BIR)的主要原因。在这里,我们表明在端粒的替代性延长(ALT)细胞中,复制应激诱导的多聚泛素化增殖细胞核抗原(PCNA)(多聚 Ub-PCNA)在端粒和常见脆弱位点(CFS)触发 BIR。一致地,消耗 PCNA 泛素化酶 RAD18 可减少与 ALT 相关的早幼粒细胞白血病(PML)体(APB)和端粒和 CFS 处的有丝分裂 DNA 合成的发生,这些都是由 BIR 介导的。相比之下,抑制泛素特异性蛋白酶 1(USP1),一种 Ub-PCNA 去泛素化酶,会导致 RAD18 和 UBE2N(PCNA 多聚泛素化酶)依赖性的上述表型增加。此外,促进 USP1 活性和卸载 PCNA 的 ATAD5 的缺乏会增强与重组相关的表型。从机制上讲,通过其泛素结合结构域,端粒上的多聚 Ub-PCNA 在端粒处积累 SLX4,一种核酸酶支架,并增加端粒损伤。一致地,Ub-PCNA 诱导的 APB 增加依赖于 SLX4 和结构特异性内切酶。总之,我们的结果确定了多聚 Ub-PCNA-SLX4 轴作为指导 BIR 的触发因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/9859f163a1b4/gkae785fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/99a5b035e405/gkae785figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/879c2d7c2b75/gkae785fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/4406dd101b20/gkae785fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/68d56fae9db9/gkae785fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/c5b3d95bff57/gkae785fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/2dd42265c3cc/gkae785fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/55ca5c6707a0/gkae785fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/ce3685814b69/gkae785fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/9859f163a1b4/gkae785fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/99a5b035e405/gkae785figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/879c2d7c2b75/gkae785fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/4406dd101b20/gkae785fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/68d56fae9db9/gkae785fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/c5b3d95bff57/gkae785fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/2dd42265c3cc/gkae785fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/55ca5c6707a0/gkae785fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/ce3685814b69/gkae785fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9e5/11514459/9859f163a1b4/gkae785fig8.jpg

相似文献

1
Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells.多聚泛素化 PCNA 触发 SLX4 介导的断裂诱导复制,在端粒延长(ALT)癌症细胞中。
Nucleic Acids Res. 2024 Oct 28;52(19):11785-11805. doi: 10.1093/nar/gkae785.
2
ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.ATAD5 作为 Ub-PCNA 去泛素化的调控平台发挥作用。
Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2315759121. doi: 10.1073/pnas.2315759121. Epub 2024 Aug 15.
3
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.泛素化 PCNA 驱动 USP1 在癌症中的合成致死性。
Mol Cancer Ther. 2023 Feb 1;22(2):215-226. doi: 10.1158/1535-7163.MCT-22-0409.
4
Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies.端粒的替代性延长是 ALT 相关的 PML 体中自我维持的过程。
Mol Cell. 2021 Mar 4;81(5):1027-1042.e4. doi: 10.1016/j.molcel.2020.12.030. Epub 2021 Jan 15.
5
Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.人类 ELG1 通过与 PCNA 和 USP1 的相互作用来调节泛素化增殖细胞核抗原 (PCNA) 的水平。
J Biol Chem. 2010 Apr 2;285(14):10362-9. doi: 10.1074/jbc.M109.092544. Epub 2010 Feb 9.
6
Break-induced replication orchestrates resection-dependent template switching.断裂诱导复制协调依赖于切除的模板转换。
Nature. 2023 Jul;619(7968):201-208. doi: 10.1038/s41586-023-06177-3. Epub 2023 Jun 14.
7
Regulation of HLTF-mediated PCNA polyubiquitination by RFC and PCNA monoubiquitination levels determines choice of damage tolerance pathway.HLTF 介导的 PCNA 多泛素化受 RFC 和 PCNA 单泛素化水平的调节,决定了损伤耐受途径的选择。
Nucleic Acids Res. 2018 Nov 30;46(21):11340-11356. doi: 10.1093/nar/gky943.
8
ATR limits Rad18-mediated PCNA monoubiquitination to preserve replication fork and telomerase-independent telomere stability.ATR 限制 Rad18 介导的 PCNA 单泛素化以维持复制叉和端粒酶独立的端粒稳定性。
EMBO J. 2024 Apr;43(7):1301-1324. doi: 10.1038/s44318-024-00066-9. Epub 2024 Mar 11.
9
En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2-E3 pairs.体外实验中,多泛素链通过两种不同的人源 E2-E3 对被连接到 PCNA 上。
Nucleic Acids Res. 2012 Nov 1;40(20):10394-407. doi: 10.1093/nar/gks763. Epub 2012 Aug 16.
10
Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen.复制蛋白 A 动态调节增殖细胞核抗原的单泛素化。
J Biol Chem. 2019 Mar 29;294(13):5157-5168. doi: 10.1074/jbc.RA118.005297. Epub 2019 Jan 30.

引用本文的文献

1
Mechanisms and genomic implications of break-induced replication.断裂诱导复制的机制及基因组影响
Nat Struct Mol Biol. 2025 Aug 22. doi: 10.1038/s41594-025-01644-z.
2
Structural and computational analysis of monkeypox virus methyltransferase: dynamic inhibition mechanisms and their implications for antiviral design.猴痘病毒甲基转移酶的结构与计算分析:动态抑制机制及其对抗病毒设计的意义
Mol Divers. 2025 Aug 13. doi: 10.1007/s11030-025-11258-8.
3
USP1/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism that can temporarily enrich for monoubiquitinated PCNA.

本文引用的文献

1
Control of telomere length in yeast by SUMOylated PCNA and the Elg1 PCNA unloader.酵母中端粒长度的控制通过 SUMO 化的 PCNA 和 Elg1 PCNA 卸载物实现。
Elife. 2023 Aug 2;12:RP86990. doi: 10.7554/eLife.86990.
2
Break-induced replication orchestrates resection-dependent template switching.断裂诱导复制协调依赖于切除的模板转换。
Nature. 2023 Jul;619(7968):201-208. doi: 10.1038/s41586-023-06177-3. Epub 2023 Jun 14.
3
Mitotic DNA synthesis in response to replication stress requires the sequential action of DNA polymerases zeta and delta in human cells.
USP1/UAF1通过一种外切切割机制靶向多聚泛素化的增殖细胞核抗原(PCNA),该机制可暂时富集单泛素化的PCNA。
Nat Commun. 2025 Jul 30;16(1):6991. doi: 10.1038/s41467-025-61768-0.
4
The ubiquitin protease Ubp10 suppresses the formation of translocations at Cdc13 binding sites.泛素蛋白酶Ubp10抑制在Cdc13结合位点处易位的形成。
bioRxiv. 2025 Jun 28:2025.06.27.661970. doi: 10.1101/2025.06.27.661970.
5
Explainable Machine Learning Identifies Factors for Dosage Compensation in Aneuploid Human Cancer Cells.可解释的机器学习识别非整倍体人类癌细胞中剂量补偿的因素。
bioRxiv. 2025 May 13:2025.05.12.653427. doi: 10.1101/2025.05.12.653427.
6
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma.靶向PCNA/PARP1轴可抑制肝细胞癌的恶性进展。
Front Pharmacol. 2025 Apr 17;16:1571786. doi: 10.3389/fphar.2025.1571786. eCollection 2025.
7
Cell Type Specific Suppression of Hyper-Recombination by Human RAD18 Is Linked to Proliferating Cell Nuclear Antigen K164 Ubiquitination.人RAD18对超重组的细胞类型特异性抑制与增殖细胞核抗原K164泛素化有关。
Biomolecules. 2025 Jan 20;15(1):150. doi: 10.3390/biom15010150.
有丝分裂 DNA 合成对复制应激的反应需要 DNA 聚合酶 zeta 和 delta 在人类细胞中的顺序作用。
Nat Commun. 2023 Feb 9;14(1):706. doi: 10.1038/s41467-023-35992-5.
4
Sources, resolution and physiological relevance of R-loops and RNA-DNA hybrids.R 环和 RNA-DNA 杂交的来源、分辨率和生理相关性。
Nat Rev Mol Cell Biol. 2022 Aug;23(8):521-540. doi: 10.1038/s41580-022-00474-x. Epub 2022 Apr 22.
5
DNA replication is highly resilient and persistent under the challenge of mild replication stress.DNA 复制具有高度的弹性和持久性,能够在轻度复制压力的挑战下持续进行。
Cell Rep. 2022 Apr 19;39(3):110701. doi: 10.1016/j.celrep.2022.110701.
6
Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.端粒复制应激:端粒的替代延长与癌症的开始和结束。
Open Biol. 2022 Mar;12(3):220011. doi: 10.1098/rsob.220011. Epub 2022 Mar 9.
7
Timely termination of repair DNA synthesis by ATAD5 is important in oxidative DNA damage-induced single-strand break repair.及时终止 ATAD5 的修复 DNA 合成对于氧化 DNA 损伤诱导的单链断裂修复很重要。
Nucleic Acids Res. 2021 Nov 18;49(20):11746-11764. doi: 10.1093/nar/gkab999.
8
RNF168 E3 ligase participates in ubiquitin signaling and recruitment of SLX4 during DNA crosslink repair.RNF168 E3 连接酶参与 DNA 交联修复过程中的泛素信号传递和 SLX4 的募集。
Cell Rep. 2021 Oct 26;37(4):109879. doi: 10.1016/j.celrep.2021.109879.
9
The RAD51 recombinase protects mitotic chromatin in human cells.RAD51 重组酶在人类细胞中保护有丝分裂染色质。
Nat Commun. 2021 Sep 10;12(1):5380. doi: 10.1038/s41467-021-25643-y.
10
G-quadruplexes mark alternative lengthening of telomeres.G-四链体标记端粒的替代延长。
NAR Cancer. 2021 Jul 21;3(3):zcab031. doi: 10.1093/narcan/zcab031. eCollection 2021 Sep.